Results 1 to 10 of about 554,415 (220)
Annals of African Medicine, 2017 Male breast cancer (MBC) is a rare disease representing less than 1% of all breast cancers (BC) and less than 1% of cancers in men. Age at presentation is mostly in the late 60s. MBC is recognized as an estrogen-driven disease, specifically related to hyperestrogenism. About 20% of MBC patients have family history for BC.
Joob, Beuy, Wiwanitkit, Viroj
core +12 more sources
Future Oncology, 2010 Diagnosis and treatment modalities for female breast cancer have developed spectacularly in recent years. Unfortunately, this is not the case for male breast cancer. Because the disease is so rare, controlled clinical trials have almost never been performed and treatment is based on findings in women or small series of men.
Zurrida S +6 more
core +13 more sources
European Journal of Breast Health, 2016 Male breast cancer (MBC) is a rare disease, accounting for less than 1% of all breast cancer diagnoses worldwide. Although breast carcinomas share certain characteristics in both genders, there are notable differences.
Metin Yalaza, Aydın İnan, Mikdat Bozer
doaj +3 more sources
Quality of life in male breast cancer patients: psychosocial impacts and therapeutic strategies [PDF]
Journal of Men's HealthMale breast cancer (MBC) is a rare malignant tumor that is infrequently diagnosed in men. This leads to a lower quality of life (QOL) in men adversely affecting their overall well-being. Therefore, we aimed to summarize and disseminate the evidence on
Yeonsoo Pyo, Youn Sug Jeon
doaj +2 more sources
Triple-Negative Male Breast Cancer Presenting as Cutaneous Metastasis: A Diagnostic Rarity [PDF]
Case Reports in Oncological MedicineCancer of the male breast is a rare disease. It comprises less than 1% of all breast carcinomas and less than 1.5% of all malignant tumors in men. Male breast cancer presenting as skin metastasis is exceptionally uncommon.
Saran Lal Ajai Mokan Dasan +4 more
doaj +2 more sources
Redefining therapeutic landscapes: clinicopathological insights into low and ultra-low HER2 expression in male breast cancer [PDF]
Diagnostic PathologyObjective With the emergence of new antibody coupled drugs, the treatment decisions of patients with low and ultra-low HER2 expression have been reshaped.
Jiuyan Shang +4 more
doaj +2 more sources
CURRENT MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL FEATURES OF MALE BREAST CANCER
Journal of Surgical Sciences, 2019 Breast cancer continues to be a leading cause of death among women aged over 40 years. This type of neoplasm is diagnosed quite rarely in male sex over 60 years, with an incidence almost 100 times lower in men versus women.
A C Tutovan, G Drăghici, S M Oprescu
doaj +3 more sources
Spontaneous Regression (SR) of Male Breast Cancer (MBC): A Rare Case Highlighting Diagnostic Pitfalls and Management Caution. [PDF]
Case Rep SurgTay JC, Sia WT, Md Yusof N, Thee LJ.
europepmc +2 more sources
Factors Associated with “Survivor Identity” in Men with Breast Cancer
Current Oncology, 2021 Cancer patients vary in their comfort with the label “survivor”. Here, we explore how comfortable males with breast cancer (BC) are about accepting the label cancer “survivor”.
Kathryn L. Dalton +5 more
doaj +1 more source